Page last updated: 2024-09-02

cobaltiprotoporphyrin and Constriction, Pathologic

cobaltiprotoporphyrin has been researched along with Constriction, Pathologic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hervera, A; Leánez, S; Motterlini, R; Pol, O1

Other Studies

1 other study(ies) available for cobaltiprotoporphyrin and Constriction, Pathologic

ArticleYear
Treatment with carbon monoxide-releasing molecules and an HO-1 inducer enhances the effects and expression of µ-opioid receptors during neuropathic pain.
    Anesthesiology, 2013, Volume: 118, Issue:5

    Topics: Analgesics, Opioid; Animals; Carbon Monoxide; Constriction, Pathologic; Enkephalin, D-Penicillamine (2,5)-; Enzyme Induction; Heme Oxygenase-1; Hot Temperature; Indoles; Male; Mice; Mice, Inbred C57BL; Morphine; Neuralgia; Organometallic Compounds; Pain Measurement; Physical Stimulation; Protoporphyrins; Receptor, Cannabinoid, CB2; Receptors, Opioid, delta; Receptors, Opioid, mu

2013